Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Quantum Chemical Investigation of the Interaction of Thalidomide Monomeric, Dimeric, Trimeric, and Tetrameric Forms with Guanine DNA Nucleotide Basis in DMSO and Water Solution: A Thermodynamic and NMR Spectroscopy Analysis. | ACS Omega | 2023 | 37841183 | PubTator, text mining | PubMed |
| Discovery of a SHP2 Degrader with In Vivo Anti-Tumor Activity. | Molecules | 2023 | 37836790 | PubTator, text mining | PubMed |
| Mutated IKZF1 is an independent marker of adverse risk in acute myeloid leukemia. | Leukemia | 2023 | 37833543 | PubTator, text mining | PubMed |
| Advancing Diagnostics and Therapy to Reach Universal Cure in Childhood ALL. | J Clin Oncol | 2023 | 37820294 | PubTator, text mining | PubMed |
| Structure-based design of a phosphotyrosine-masked covalent ligand targeting the E3 ligase SOCS2. | Nat Commun | 2023 | 37816714 | PubTator, text mining | PubMed |
| High levels of CRBN isoform lacking IMiDs binding domain predicts for a worse response to IMiDs-based upfront therapy in newly diagnosed myeloma patients. | Clin Exp Med | 2023 | 37815734 | PubTator, text mining | PubMed |
| Safety and efficacy of biological agents in the treatment of Systemic Lupus Erythematosus (SLE). | BMC Rheumatol | 2023 | 37807057 | PubTator, text mining | PubMed |
| Multi-omics investigation of the resistance mechanisms of pomalidomide in multiple myeloma. | Front Oncol | 2023 | 37799465 | PubTator, text mining | PubMed |
| Antibody-drug conjugates: Recent advances in payloads. | Acta Pharm Sin B | 2023 | 37799390 | PubTator, text mining | PubMed |
| The role of E3 ubiquitin ligases in bone homeostasis and related diseases. | Acta Pharm Sin B | 2023 | 37799379 | PubTator, text mining | PubMed |
| Explosive Disease Progression After Single-Agent B-cell Maturation Antigen-Targeted Treatment in Multiple Myeloma: A Report of Three Cases in Sheikh Shakhbout Medical City. | Cureus | 2023 | 37791224 | PubTator, text mining | PubMed |
| Lenalidomide improves NKG2D-based CAR-T cell activity against colorectal cancer cells invitro. | Heliyon | 2023 | 37790973 | PubTator, text mining | PubMed |
| Pooled endogenous protein tagging and recruitment for scalable discovery of effectors for induced proximity therapeutics. | Res Sq | 2023 | 37790450 | PubTator, text mining | PubMed |
| Lupus clinical trials and the promise of future therapies. | Rheumatol Immunol Res | 2023 | 37781678 | PubTator, text mining | PubMed |
| Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress. | Int J Biol Sci | 2023 | 37781032 | PubTator, text mining | PubMed |
| A Landmark Paper That Introduced Proteasome Inhibition in Myeloma. | Cancer Res | 2023 | 37779426 | PubTator, text mining | PubMed |
| Research in the Field of Drug Design and Development. | Pharmaceuticals (Basel) | 2023 | 37765091 | PubTator, text mining | PubMed |
| Lenalidomide Promotes Thrombosis Formation, but Does Not Affect Platelet Activation in Multiple Myeloma. | Int J Mol Sci | 2023 | 37762399 | PubTator, text mining | PubMed |
| RNF126, 168 and CUL1: The Potential Utilization of Multi-Functional E3 Ubiquitin Ligases in Genome Maintenance for Cancer Therapy. | Biomedicines | 2023 | 37760968 | PubTator, text mining | PubMed |
| Targeted Therapy in Follicular Lymphoma: Towards a Chemotherapy-Free Approach. | Cancers (Basel) | 2023 | 37760453 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=29